Literature DB >> 16962190

Simulating the impact of four control strategies on the population dynamics of Neospora caninum infection in Swiss dairy cattle.

Barbara Häsler1, Katharina D C Stärk, Heinz Sager, Bruno Gottstein, Martin Reist.   

Abstract

A dynamic deterministic simulation model was developed to assess the impact of different putative control strategies on the seroprevalence of Neospora caninum in female Swiss dairy cattle. The model structure comprised compartments of "susceptible" and "infected" animals (SI-model) and the cattle population was divided into 12 age classes. A reference model (Model 1) was developed to simulate the current (status quo) situation (present seroprevalence in Switzerland 12%), taking into account available demographic and seroprevalence data of Switzerland. Model 1 was modified to represent four putative control strategies: testing and culling of seropositive animals (Model 2), discontinued breeding with offspring from seropositive cows (Model 3), chemotherapeutic treatment of calves from seropositive cows (Model 4), and vaccination of susceptible and infected animals (Model 5). Models 2-4 considered different sub-scenarios with regard to the frequency of diagnostic testing. Multivariable Monte Carlo sensitivity analysis was used to assess the impact of uncertainty in input parameters. A policy of annual testing and culling of all seropositive cattle in the population reduced the seroprevalence effectively and rapidly from 12% to <1% in the first year of simulation. The control strategies with discontinued breeding with offspring from all seropositive cows, chemotherapy of calves and vaccination of all cattle reduced the prevalence more slowly than culling but were still very effective (reduction of prevalence below 2% within 11, 23 and 3 years of simulation, respectively). However, sensitivity analyses revealed that the effectiveness of these strategies depended strongly on the quality of the input parameters used, such as the horizontal and vertical transmission factors, the sensitivity of the diagnostic test and the efficacy of medication and vaccination. Finally, all models confirmed that it was not possible to completely eradicate N. caninum as long as the horizontal transmission process was not interrupted.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16962190     DOI: 10.1016/j.prevetmed.2006.07.007

Source DB:  PubMed          Journal:  Prev Vet Med        ISSN: 0167-5877            Impact factor:   2.670


  10 in total

1.  Neospora caninum causes severe economic losses in cattle in the humid pampa region of Argentina.

Authors:  Dadin Moore; Michael Reichel; Ernesto Spath; Carlos Campero
Journal:  Trop Anim Health Prod       Date:  2013-01-17       Impact factor: 1.559

2.  Host cells participate in the in vitro effects of novel diamidine analogues against tachyzoites of the intracellular apicomplexan parasites Neospora caninum and Toxoplasma gondii.

Authors:  Angela Leepin; Angela Stüdli; Reto Brun; Chad E Stephens; David W Boykin; Andrew Hemphill
Journal:  Antimicrob Agents Chemother       Date:  2008-03-24       Impact factor: 5.191

3.  Toltrazuril treatment of congenitally acquired Neospora caninum infection in newborn mice.

Authors:  M Strohbusch; N Müller; A Hemphill; R Krebber; G Greif; B Gottstein
Journal:  Parasitol Res       Date:  2009-02-10       Impact factor: 2.289

Review 4.  Epidemiology and control of neosporosis and Neospora caninum.

Authors:  J P Dubey; G Schares; L M Ortega-Mora
Journal:  Clin Microbiol Rev       Date:  2007-04       Impact factor: 26.132

5.  Di-cationic arylimidamides act against Neospora caninum tachyzoites by interference in membrane structure and nucleolar integrity and are active against challenge infection in mice.

Authors:  Michelle Schorer; Karim Debache; Fabienne Barna; Thierry Monney; Joachim Müller; David W Boykin; Chad E Stephens; Andrew Hemphill
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-04-02       Impact factor: 4.077

6.  In vitro effects of novel ruthenium complexes in Neospora caninum and Toxoplasma gondii tachyzoites.

Authors:  Fabienne Barna; Karim Debache; Carsten A Vock; Tatiana Küster; Andrew Hemphill
Journal:  Antimicrob Agents Chemother       Date:  2013-08-26       Impact factor: 5.191

Review 7.  Vaccines against a Major Cause of Abortion in Cattle, Neospora caninum Infection.

Authors:  Thierry Monney; Karim Debache; Andrew Hemphill
Journal:  Animals (Basel)       Date:  2011-09-08       Impact factor: 2.752

8.  Buparvaquone is active against Neospora caninum in vitro and in experimentally infected mice.

Authors:  Joachim Müller; Adriana Aguado-Martinez; Vera Manser; Vreni Balmer; Pablo Winzer; Dominic Ritler; Isabel Hostettler; David Arranz-Solís; Luis Ortega-Mora; Andrew Hemphill
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2015-02-13       Impact factor: 4.077

9.  Safety and efficacy of the bumped kinase inhibitor BKI-1553 in pregnant sheep experimentally infected with Neospora caninum tachyzoites.

Authors:  Roberto Sánchez-Sánchez; Ignacio Ferre; Michela Re; Patricia Vázquez; Luis Miguel Ferrer; Javier Blanco-Murcia; Javier Regidor-Cerrillo; Manuel Pizarro Díaz; Marta González-Huecas; Enrique Tabanera; Paula García-Lunar; Julio Benavides; Pablo Castaño; Andrew Hemphill; Matthew A Hulverson; Grant R Whitman; Kasey L Rivas; Ryan Choi; Kayode K Ojo; Lynn K Barrett; Wesley C Van Voorhis; Luis Miguel Ortega-Mora
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2018-03-02       Impact factor: 4.077

10.  Repurposing of antiparasitic drugs: the hydroxy-naphthoquinone buparvaquone inhibits vertical transmission in the pregnant neosporosis mouse model.

Authors:  Joachim Müller; Adriana Aguado-Martínez; Vera Manser; Ho Ning Wong; Richard K Haynes; Andrew Hemphill
Journal:  Vet Res       Date:  2016-02-17       Impact factor: 3.683

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.